Bifogade filer
Download announcement as PDF
Kurs
-1,29%
Kurs
-1,29%
Open
4,20
High
4,30
Low
3,94
Close
4,20
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
17,6 MNOK
Likviditet
17,6 MNOK
Rel. mcap
1,12%
Antal aktier
4 271 482
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2026-04-23 | N/A | Årsstämma |
| 2026-02-26 | 07:00 | Bokslutskommuniké 2025 |
| 2025-08-29 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-25 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2025-04-24 | - | Årsstämma |
| 2025-02-26 | - | Bokslutskommuniké 2024 |
| 2025-01-06 | - | Extra Bolagsstämma 2025 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-12 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2024-04-11 | - | Årsstämma |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-08-31 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-27 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2023-04-26 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-08-31 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2022-04-28 | - | Årsstämma |
| 2022-03-01 | - | Bokslutskommuniké 2021 |
| 2021-11-18 | - | 15-10 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-26 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-28 | - | Årsstämma |
| 2021-04-16 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2021-03-22 | - | Extra Bolagsstämma 2021 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-19 | - | Kvartalsrapport 2020-Q3 |
| 2020-10-21 | - | Extra Bolagsstämma 2020 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-11 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2020-06-10 | - | Årsstämma |
| 2020-05-26 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-19 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-26 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2019-04-25 | - | Årsstämma |
| 2019-02-18 | - | Extra Bolagsstämma 2019 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-31 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2018-05-30 | - | Årsstämma |
| 2018-05-30 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-12-20 | - | Extra Bolagsstämma 2017 |
| 2017-11-22 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-23 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-26 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2017-05-24 | - | Årsstämma |
| 2017-05-24 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-11-23 | - | Kvartalsrapport 2016-Q3 |
| 2016-10-12 | - | Extra Bolagsstämma 2016 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-31 | - | Kapitalmarknadsdag 2016 |
| 2016-05-20 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2016-05-19 | - | Årsstämma |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-26 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kapitalmarknadsdag 2015 |
| 2015-10-21 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-27 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-09 | - | Årsstämma |
| 2014-11-12 | - | Extra Bolagsstämma 2014 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2026-02-18 07:00:03
18.2.2026 07:00:00 CET | Thor Medical ASA | Non-regulatory press releases
Thor Medical ASA will publish its second-half and full-year 2025 results on
Thursday, February 26, 2026, at 07:00 CET.
The company will host a presentation of the results at 08:00 CET the same day at
Sjølyst Møtesenter, Drammensveien 165, Oslo. Investors, analysts and media are
invited to attend.
Date: Thursday, February 26, 2026
Time: 08:00 CET
Venue: Sjølyst Møtesenter, Drammensveien 165, Oslo
Webcast: https://qcnl.tv/p/oaKSlZtoFMGAjpGTZIKcdg -
https://nor01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fqcnl.tv%2Fp%2F
oaKSlZtoFMGAjpGTZIKcdg&data=05%7C02%7C%7C49a6bd5b0d794cb377a508de6d35f2a7%7C18d5
60945f654afda565a84b07f106b0%7C0%7C0%7C639068275629967674%7CUnknown%7CTWFpbGZsb3
d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIl
dUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=gUG3dfimV2zYzWSKJrOMryzhJUeZE17BHqoelQNqYs4%3D
&reserved=0
The interim financial report for the second half and full year of 2025, and
presentation material, will be released at 07:00 CET and made available on
www.thormedical.com - http://www.thormedical.com
CONTACTS
Mathias Nilsen Reierth, Head of Communications and Corporate Affairs, Thor
Medical ASA, +47 988 05 724, mathias.reierth@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of alpha particle emitters produced from
naturally occurring thorium. Its proprietary production process requires no
irradiation or use of nuclear reactors, and provides reliable, environmentally
friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical
industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit
www.thormedical.com - http://www.thormedical.com.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18808516/6798/Download%20announce
ment%20as%20PDF.pdf